References
- Duque O. Cromoblastomicosis. Antioquia Médica 1962; 11: 499–521
- Rippon JW. The pathogenic fungi and the pathogenic actino-mycetes. Chromoblastomycosis. Medical Mycology3rd edn. WB Saunders Company, Philadelphia, PA 1988; 276–296, In
- Resprepo A, González A, Gómez I, Arango M, DeBedout C. Treatment of chromoblastomycosis with itraconazole. Ann NY AcadSci 1988; 544: 504–516
- Borelli D. A method for producing chromomycosis in mice. Trans Roy Soc Trop Med Hyg 1972; 66: 793–794
- Ahrens J, Graybill JR, Abishawl A, Tio OF, Rinaldi MG. Experimental murine chromomycosis mimicking chronic progressive humandisease. Am J Trop Med Hyg 1989; 6: 651–658
- Polak A. Experimental infection of mice by Fonsecaea pedrosoi and Wangiella dermatitidis. Sabouraudia 1984; 22: 167–169
- Kurita N. Cell-mediated immune responses in mice infected with Fonsecaea pedrosoi. Mycopathologia 1979; 68: 9–15
- Nishimura K, Miyaji M. Defense mechanisms of mice against Fonsecaea pedrosoi infection. Mycopathologia 1981; 76: 155–166
- Silva CL, Fazioli RA. Role of the fungal cell wall in the granulomatous response of mice to the agents of chromomycosis. J Med Microbiol 1985; 20: 299–305
- Rozental S, Alviano CS, de Souza W. The in vitro susceptibility of Fonsecaea pedrosoi to activated macrophages. Mycopathologia 1994; 126: 85–91